Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
01/2008
01/10/2008WO2008003690A1 Azatricyclic compounds and their use
01/10/2008WO2008003667A2 Combinations of monoamine reuptake inhibitors and potassium channel activators
01/10/2008WO2008003665A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
01/10/2008WO2008003637A2 Isolation and use of amine salts of mycophenolic acid
01/10/2008WO2008003611A1 Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-hsd 1)
01/10/2008WO2008003511A1 Use of aminothiazole derivative compounds, pharmaceutical compositions thereof, in the treatment of diseases characterized by abnormal repression of gene transcription, particularly huntington's disease
01/10/2008WO2008003510A1 Naphthofuranone derivatives as specific inhibitors of thymidylate synthases
01/10/2008WO2008003484A2 Agent containing chrysin and cholic acid for reducing weight, accelerating lipid catabolism, and/or restricting calories
01/10/2008WO2008003479A1 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
01/10/2008WO2008003475A1 Preparation for preventing ageing symptoms containing phytoestrogens and melatonin
01/10/2008WO2008003452A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators
01/10/2008WO2008003432A1 Pharmaceutical composition containing a tetrahydrofolic acid
01/10/2008WO2008003424A1 Substituted benzoxepino-isoxazoles and use thereof
01/10/2008WO2008003414A1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid
01/10/2008WO2008003412A1 The use of 1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension
01/10/2008WO2008003396A1 Indazole derivatives for treating hsp90-induced diseases
01/10/2008WO2008003378A1 Sulfamate benzothiophene derivatives
01/10/2008WO2008003363A1 Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations
01/10/2008WO2008003314A1 A method of preparing a glycoside of a mono- or diacylglycerol product from a plant material
01/10/2008WO2008003299A1 Basic acetophenones as inhibitors of no-synthases
01/10/2008WO2008003245A1 The use of rosmarinic acid in the manufacture of medicaments for treating or preventing hepatic and renal diseases
01/10/2008WO2008003242A1 Method and ophthalmic formulation for eye protection or treatment
01/10/2008WO2008003155A2 Methods to prepare penta-1,4-dien-3-ones and substituted cyclohexanones and derivatives with antitumoral and antiparasitic properties, the compounds and their uses
01/10/2008WO2008003141A1 Therapeutic compounds
01/10/2008WO2008003130A1 A method and composition for treating the scalp
01/10/2008WO2007137206A3 Unit dose formulations comprising an inhalable solution of albuterol
01/10/2008WO2007137190A3 Functionally diverse macromolecules and their synthesis
01/10/2008WO2007137107A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
01/10/2008WO2007136689A3 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
01/10/2008WO2007136680A3 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
01/10/2008WO2007136577A3 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
01/10/2008WO2007136572A3 Antidiabetic bicyclic compounds
01/10/2008WO2007135466A3 Substituted n-acyl homoserine lactones
01/10/2008WO2007135295A3 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
01/10/2008WO2007135080A3 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them
01/10/2008WO2007134292A3 Treprostinil administration using a metered dose inhaler
01/10/2008WO2007134149A3 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors
01/10/2008WO2007134085A3 Isothiazolidines useful in the treatment of ocular hypertensive conditions
01/10/2008WO2007133803A3 Treatment of mycobacterial infections
01/10/2008WO2007133614A3 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors
01/10/2008WO2007133473A3 Methods for treating or preventing disorders using ecdysteroid compositions
01/10/2008WO2007132134A3 Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, methods for preparing same, and uses thereof
01/10/2008WO2007131982A3 Substituted prolinamides, production thereof and their use as drugs
01/10/2008WO2007131764A3 New heterocyclic compounds for the inhibition of integrins and use thereof
01/10/2008WO2007130509A3 Pyrroloquinoline quinones and use thereof
01/10/2008WO2007130499A3 Antiviral agents
01/10/2008WO2007128987A3 Therapy targeting cathepsin s
01/10/2008WO2007125501A3 Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
01/10/2008WO2007125492A3 Acidic composition
01/10/2008WO2007122591A3 Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists
01/10/2008WO2007122478A3 Multiple unit compositions
01/10/2008WO2007122382A3 Lycopene for the treatment of metabolic dysfunction
01/10/2008WO2007121921A3 Purine derivatives for use as adenosin a2a receptor agonists
01/10/2008WO2007121920A3 Purine derivatives for use as adenosin a2a receptor agonists
01/10/2008WO2007120333A3 Tetracyclic kinase inhibitors
01/10/2008WO2007117995A3 Kinase inhibitors
01/10/2008WO2007117715A3 Modulators of atp-binding cassette transporters
01/10/2008WO2007117692A3 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
01/10/2008WO2007117549A3 Co-administration of adenosine a1 receptor antagonists and anticonvulsants
01/10/2008WO2007116313A3 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
01/10/2008WO2007116297A3 Use of aminapthone for the preparation of a medicament for treating arteriophaties
01/10/2008WO2007115726A3 The homeobox transcription factor bsx and uses thereof for treating diseases, in particular obesity
01/10/2008WO2007110047B1 TERGURIDE/PROTERGURIDE FOR THE TREATMENT OF CHRONIC PAIN (e.g. MIGRAINE)
01/10/2008WO2007104652A3 Non-peptidic renin inhibitors nitroderivatives
01/10/2008WO2007104575A3 Stable lozenge compositions providing rapid release of nicotine
01/10/2008WO2007104574A3 Chewing gum compositions providing rapid release of nicotine
01/10/2008WO2007103432A9 Use of pyrazolo[1,5a]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders
01/10/2008WO2007095949A3 Improved preparation of molecular imprinted polymers
01/10/2008WO2007093853A3 Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols
01/10/2008WO2007084661B1 Therapy-enhancing glucan
01/10/2008WO2007081910A3 Compositions and methods of treatment using modulators of motonueron diseases
01/10/2008WO2007067515A3 Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis therapeutics
01/10/2008WO2007067511A3 Morpholine carboxamide prokineticin receptor antagonists
01/10/2008WO2007064932A3 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
01/10/2008WO2007061862A3 2-keto-oxazoles as modulators of fatty acid amide hydrolase
01/10/2008WO2007060458A3 Treatment of ophthalmic diseases with beta-amino alcohols
01/10/2008WO2007059916A3 Pharmaceutical composition
01/10/2008WO2007057457A3 Neuroendocrine tumor treatment using mtor inhibitors
01/10/2008WO2007053847A3 Reducing cellular cholesterol levels and/or treating or preventing phospholipidosis
01/10/2008WO2007050425A3 Lxr modulators
01/10/2008WO2007038241A3 Modulation of mesenchymal and metastatic cell growth
01/10/2008WO2007026725A3 Drug, drug gudance system, magnetic detection system, and drug design method
01/10/2008WO2007024492A3 Medical devices and coatings therefore comprising biodegradable polymers with enhanced functionality
01/10/2008WO2007022478A3 Transcription factors in neuronal dendrites-dendritic protein synthesis and cell death
01/10/2008WO2007021803A8 Compounds for the treatment of inflammatory disorders
01/10/2008WO2007016532A3 Mutations and polymorphisms of hdac4
01/10/2008WO2007008490A3 Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer
01/10/2008WO2007006922A8 Novel 1h-indole-pyridinecarboxamide derivatives and 1h-indole-piperidinecarboxamide and their use as hydroxylase tyrosine inducers
01/10/2008WO2007003330A3 Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist
01/10/2008WO2006135621A3 Method for renin-angiotensin-aldosterone system activation and control thereof
01/10/2008WO2006130500A8 Tigecycline and methods of preparing 9-aminominocycline
01/10/2008WO2006108879A3 Use of a sulfonamide compound for improving the pharmacokinetics of a drug
01/10/2008WO2006108488A8 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
01/10/2008WO2006098834A8 Crystalline forms of ziprasidone mesylate
01/10/2008WO2006091766A3 Human trophoblast stem cells and use thereof
01/10/2008WO2006074187A3 Method of treating brain cancer
01/10/2008WO2006036055A3 Method of female contraception and kit for use in such method
01/10/2008WO2005042002A3 Treatment of rhematoid arthritis with flip antagonists
01/10/2008WO2004108056A3 Packing, or kit of medicaments, or facilitating presentation of administering of medicaments on the part of individuals under preventive situation and/or treatment of the atherosclerosis disease
01/10/2008US20080009552 Markers of pre-term labor